qsymia pillQsymia is an appetite suppressant pill available in extended-release formulation that contains a mixture of Phentermine and topiramate in its medicinal composition. The medication is used for treating obesity and overweight condition alongside following a fat-free diet plan and exercise regimen. Very often, the medication is recommended for treating diabetes that is caused as a resultant effect of high cholesterol, high blood pressure and diabetes medical conditions. One of its mixture Topiramate is an anticonvulsant medication used for treating seizures in people of all age groups.

Product Description

Qsymia is manufactured by Vivus Inc. The food and Drug administration department of U.S approved the pill in the year 2012. As per FDA guidelines, the medication should be administered only by adults with a maximum body mass index (BMI) of 30 kg/m2 or the least BMI should be 27 kg/m², and all the more the person concerned should be experiencing either any one of the overweight symptoms like type 2 diabetes mellitus, and diabetes.

How to take Qsymia?

There are no special recommendations when it comes to the consumption pattern of the pill. The pill can be taken with food or without food. As like any other medication, never attempt to crush, open or break the pill at any cost. It ought to be swallowed as a one single tablet. Whilst taking Qsymia ensure that you drink plenty of water so as to stay protected against dehydration and lessen the possible risk of kidney stones. By consuming the pill and following a low-calorie diet regimen, one can be assured of losing 3% of the body weight in the initial 12 weeks of the treatment.

Dosages available for Cheap Qsymia

cheap qysmiaFor the first 14 days, the medication should be taken in the lowest possible dose i.e. phentermine 3.75mg/ topiramate 23 mg extended-release. Please note that the medication should be taken only once in a day. Upon completion of 14days of the initial therapy, the dosage strength can be slightly increased i.e. phentermine 7.5 mg/topiramate 46 mg extended-release capsule. The extent of weight loss should be analyzed after 12 weeks of the treatment. Those individuals who haven’t lost 3% of the body weight should opt for dose escalation, as it should be inferred that a person has very less chance of reducing the body weight in the current dosage strength. Missed dose if any should be administered in the immediate instance upon remembrance. The medication should be taken only upon obtaining doctor’s consent.

Leave a Reply